|
STK24 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.328400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.278200E-01 |
| Normal-vs-Stage2 |
4.929200E-01 |
| Normal-vs-Stage3 |
7.348000E-01 |
| Normal-vs-Stage4 |
2.327800E-01 |
| Stage1-vs-Stage2 |
1.429010E-01 |
| Stage1-vs-Stage3 |
1.803180E-01 |
| Stage1-vs-Stage4 |
6.507400E-01 |
| Stage2-vs-Stage3 |
6.175400E-01 |
| Stage2-vs-Stage4 |
1.277620E-01 |
| Stage3-vs-Stage4 |
1.411210E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.284800E-01 |
| Normal-vs-AfricanAmerican |
2.132600E-01 |
| Normal-vs-Asian |
1.838190E-01 |
| Caucasian-vs-AfricanAmerican |
2.765000E-01 |
| Caucasian-vs-Asian |
2.679400E-01 |
| AfricanAmerican-vs-Asian |
8.225400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.161600E-01 |
| Normal-vs-Female |
3.820800E-01 |
| Male-vs-Female |
2.985600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.491760E-01 |
| Normal-vs-Age(41-60Yrs) |
4.269200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.031760E-01 |
| Normal-vs-Age(81-100Yrs) |
1.036030E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.117600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.202100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.021700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.619900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.115770E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.806200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.760200E-01 |
| Classical-VS-Follicular |
1.69070000222149E-08 |
| Classical-VS-Other |
7.817400E-01 |
| Classical-VS-Normal |
4.596500E-02 |
| Tall-VS-Follicular |
5.96419999999709E-05 |
| Tall-VS-Other |
7.227800E-01 |
| Tall-VS-Normal |
6.826200E-02 |
| Follicular-VS-Other |
1.674790E-01 |
| Follicular-VS-Normal |
5.122400E-03 |
| Other-VS-Normal |
7.755600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.607600E-01 |
| Normal-vs-N1 |
7.530200E-01 |
| N0-vs-N1 |
7.216000E-01 |
|
|
